This observation might suggest that the increase of I-FABP in some COVID-19 patients might depend on the combination of pathological conditions that are in fine associated with marked alterations of the intestinal barrier, or perhaps related to bacterial diseases rather than viral diseases. Here, FABP2 is linked to viral infectious disease.